"Peanut Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Allergic reaction to peanuts that is triggered by the immune system.
| Descriptor ID |
D021183
|
| MeSH Number(s) |
C20.543.480.370.572.750
|
| Concept/Terms |
Peanut Hypersensitivity- Peanut Hypersensitivity
- Groundnut Hypersensitivity
- Hypersensitivity, Groundnut
- Allergy, Peanut
- Allergies, Peanut
- Peanut Allergies
- Hypersensitivity, Peanut
- Peanut Allergy
|
Below are MeSH descriptors whose meaning is more general than "Peanut Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Peanut Hypersensitivity".
This graph shows the total number of publications written about "Peanut Hypersensitivity" by people in this website by year, and whether "Peanut Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 16 | 3 | 19 |
| 2018 | 13 | 2 | 15 |
| 2019 | 7 | 0 | 7 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Peanut Hypersensitivity" by people in Profiles.
-
The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go. J Allergy Clin Immunol Pract. 2021 11; 9(11):3911-3917.
-
Emerging developments in the forefront of peanut oral immunotherapy. Curr Opin Allergy Clin Immunol. 2021 06 01; 21(3):263-268.
-
Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3259-3260.
-
Virtually supported home peanut introduction during COVID-19 for at-risk infants. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2780-2783.
-
Pre-emptive screening for peanut allergy before peanut ingestion in infants is not standard of care. CMAJ. 2019 10 21; 191(42):E1169-E1170.
-
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendations. J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2901-2903.e3.
-
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019 06 01; 393(10187):2222-2232.
-
First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy. J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2759-2767.e5.
-
Changing Patient Mindsets about Non-Life-Threatening Symptoms During Oral Immunotherapy: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1550-1559.
-
Allergen-specific CD8+ T cells in peanut-allergic individuals. J Allergy Clin Immunol. 2019 05; 143(5):1948-1952.